A Psychometric Analysis of the MDS UPDRS-II and III in Early Parkinson’s disease: Do the Numbers Add Up?
Objective: Our objective was to explore the psychometric evidence for the use of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) part II…Rasch analysis of the Hospital Anxiety and Depression Scale among patients with early-stage Parkinson’s disease
Objective: We aim to assess the psychometric properties of the Korean version of Hospital Anxiety and Depression Scale (HADS) in a sample of early-stage Parkinson's…The International Parkinson and Movement Disorder Society Non-Motor Scale (MDS-NMS) for Parkinson’s Disease: Preliminary results from an international validation
Objective: To provide an update on the ongoing international validation programme of an expanded, refined and improved scale for the assessment of non-motor symptoms (NMS)…The Reliability Study of King’s Parkinson’s Disease Pain Scale in Indonesian Version
Objective: To create the reliable Indonesian Version of King’s Parkinson’s Disease Pain Scale. Background: Pain is one of the most common non-motor symptoms of Parkinson’s…FuRST2.0: Development of a modified functional rating scale for use in premanifest and early-manifest Huntington’s disease
Objective: Develop a patient-reported outcome (PRO) modification of the Functional Rating Scale for pre-Huntington Disease (FuRST-pHD) using focus group, Delphi panel and cognitive pre-testing methodology.…Usefulness of a simple symptom assessment scale for multiple system atrophy: data from HoRC-MSA Project
Objective: To investigate the usefulness of a symptom assessment scale for multiple system atrophy (MSA) in Hokkaido, Japan from the data of the Hokkaido Rare-disease…Prevalence of Patient-Reported Symptoms of Dysphonia and Dysphagia in Movement Disorder Patients at an Academic Medical Center
Objective: To determine the prevalence of patient-reported quality of life (QOL) measures of dysphonia and dysphagia in movement disorder patients at an academic medical center.…Pilot study of a new tool to optimize dopaminergic treatment in Parkinson’s disease: The OPTIPARK Scale Project
Objective: Our objective was to develop and pilot test a scale (OPTIPARK) for assessing a patient´s dopaminergic state, allowing the clinician to consider the adjustment…Preliminary Results of Psychometric Properties of the Turkish version of Falls Efficacy Scale – International in Patients with Parkinson’s Disease
Objective: To assess the psychometric properties of the Turkish version of Falls Efficacy Scale - International (FES-I) in Parkinson’s disease (PD) patients. Background: Fear of…Are the MDS-UPDRS-based composite scores clinically applicable?
Objective: Our aim is to evaluate the feasibility of various composite scores based on the Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) as…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.